Effective March 1, 2021, internist-endocrinologist Romana Netea-Maier has been appointed Professor of Endocrine Tumors at Radboud university medical center/Radboud University. She will focus on research into the pathogenesis, treatment and consequences of endocrine tumors, particularly tumors of the thyroid gland.
With clinical-scientific research focused on the role of inflammation and the immune response in the development of endocrine tumors, Romana Netea-Maier's research group is taking the lead in the field of therapy resistant tumors to identify new targets for treatment. In doing so, she focuses particularly on the rare advanced forms of thyroid cancer, for which there are currently insufficient therapy options available. In addition, she investigates the long-term consequences of endocrine tumors. For her research, she collaborates with several national and international networks and with the Dutch patient organization Thyroid Organization Netherlands (SON).
Romana Netea-Maier (1969, Sibiu (Romania)) studied Medicine at the 'Iuliu Hatieganu' University of Medicine and Pharmacology in Cluj-Napoca (Romania) and Radboud University in Nijmegen. She received her PhD in 2002 for her thesis “Blood pressure measurement: practical aspects of the procedure”.
Radboud university medical center as a person-centered care center
After her PhD, Romana Netea-Maier continued her training as an internist-endocrinologist at the Radboud university medical center. In 2005 she was a postdoctoral scientist at the University of Colorado Health Science Centre Denver (USA). Since 2009, she has led the Endocrine Tumors board of the Radboudumc Center of Expertise for Thyroid Carcinoma, and in 2017 she has been appointed as associate professor of Endocrine Tumors. Patient participation and empowerment are central themes in her work as a clinician and researcher. Romana Netea-Maier: "I strongly believe that top quality patient care combined with leading scientific research is reflected in the quality of life of our patients. As a professor I intend to commit myself to this principle."
Romana Netea-Maier is also committed to the development of the Radboud university medical center as a healthcare center where patients with thyroid tumors receive person-centered, efficient, patient-friendly and high-quality diagnostics, treatment and guidance. Romana Netea-Maier is a board member of the Dutch Thyroid Research Foundation and the Dutch Thyroid Cancer Group. She is a member of the Steering Committee of the EORTC Endocrine Tumors group.
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
ZonMw Open Competition Grant for Annemiek van Spriel and Piet Gros15 June 2021
Annemiek van Spriel, theme cancer development and immune defense, together with Piet Gros, Dept. of Chemistry, Utrecht University obtained a ZonMw Open Competition Grant to investigate IL-6 receptor structure and signalling in tumor cells.read more
Human microbiome could shed light on higher morbidity rate in minoritized populations The link between environmental inequities and disease may lie in the gut15 June 2021
A study published in PNAS is the first to explicitly address the gut microbiome as a pathway to understanding how environmental inequities could lead to health disparities.read more
New ultra-high field MRI system available for Radboudumc and Radboud University10 June 2021
Recently, the Hahn institute in Essen has received a new heart: a 20-ton ultra-high-field MRI scanner from Siemens Healthcare with a magnetic field strength of 7 Tesla. The new CE-approved scanner is ready for business, and projects on body and brain imaging are starting up.read more
On the prevalence of cerebral amyloid angiopathy a systematic review and meta-analysis10 June 2021
Published in ‘Alzheimers and Dementia’, researchers at Radboudumc performed a systematic review and meta-analysis on the prevalence of Cerebral Amyloid Angiopathy. They scrutinized and analyzed 170 publications, comprising publications using either a neuroimaging or a neuropathological approach.read more
Retina-on-chip modeling and treating eye diseases in a dish10 June 2021
Alex Garanto, together with Anneke den Hollander and Andries van der Meer (UTwente) have received 1,17M€ to develop a retina-on-chip model to improve our understanding in eye diseases and to develop treatments against them.read more
New method to prevent ovarian cancer increases quality of life8 June 2021
Researchers at Radboudumc have shown that quality of life is better in women with a BRCA1 or BRCA2 mutation after fallopian tube removal with delayed ovarian removal to prevent ovarian cancer.read more